Ondansetron Injection, Solution
Product Images NDC 55150-125

5 FDA label images from Eugia Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55150-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (40 mg per 20 mL Container Label)

Package Label-principal Display Panel (40 mg per 20 mL Container Label)
Ondansetron Injection, USP 40 mg per 20 mL (2 mg/mL) solution for injection, labeled for intravenous or intramuscular use. The sterile product is in a 20 mL multidose vial. Distributed by AuroMedics Pharma LLC and made in India. The label includes active ingredient and storage information.*
FDA Label Image

Package Label-principal Display Panel (40 mg per 20 mL Container-Carton (1 Vial))

Package Label-principal Display Panel (40 mg per 20 mL Container-Carton (1 Vial))
Packaging label for Ondansetron Injection, USP 40 mg per 20 mL (2 mg/mL) multidose vial by Auromedics. The label indicates the product is sterile, intended for intravenous or intramuscular injection, with storage instructions at 20° to 25°C. Distributed by AuroMedics Pharma LLC and made in India. Includes NDC 55150-126-20 and barcode.*
FDA Label Image

Ondansetron Fig3

Ondansetron Fig3
Ondansetron Injection, USP 4 mg per 2 mL (2 mg/mL) single-dose vial label. Injection solution for intravenous or intramuscular use, 2 mL vial. Distributed by AuroMedics Pharma LLC, made in India. Includes NDC 55150-125-02 and barcode.*
FDA Label Image

Ondansetron Fig4

Ondansetron Fig4
Ondansetron Injection, USP 4 mg per 2 mL (2 mg/mL) solution for injection packaging label by Auromedics. This sterile product is supplied as 25 single-dose vials of 2 mL each, intended for intravenous or intramuscular administration. The label states the vial stopper is non-latex and includes distributor information for AuroMedics Pharma LLC, New Jersey, USA. Product is made in India.*
FDA Label Image

Ondansetron Hydrochloride Chemical Struture (Ondansetron Str)

Ondansetron Hydrochloride Chemical Struture (Ondansetron Str)
Chemical structure of Ondansetron Hydrochloride. The diagram shows the molecular arrangement including a fused ring system and multiple functional groups labeled with atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.